By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Novartis Pharmaceuticals Corporation 

One Health Plaza

East Hanover  New Jersey  07936-1080  U.S.A.
Phone: 973-781-8300 Fax: 973-781-8265


SEARCH JOBS




Collaborations

Vicuron Pharmaceuticals, Inc.  Deformylase and MUR: Pathway inhibitors for novel mechanism based antimicrobial drugs





Company News
ASCO2016: Novartis Pharmaceuticals Corporation (NVS) Combination Therapy Tafinlar + Mekinist Demonstrates Overall Survival Benefit At Three-Year Follow-Up In Patients With Advanced Melanoma 6/7/2016 11:41:08 AM
ASCO2016: Novartis Pharmaceuticals Corporation (NVS) Data Show More Than 50 Percent Of Eligible Ph+ CML Patients Maintain Treatment-Free Remission (TFR) After Stopping Tasigna 6/6/2016 9:57:27 AM
Novartis Pharmaceuticals Corporation (NVS) Data Show Gilenya Had Significantly Greater Patient Retention Compared To iDMTs In Relapsing-Remitting MS 6/3/2016 6:19:10 AM
Novartis Pharmaceuticals Corporation (NVS) Announces US Collaboration To Co-Promote Lenvima In Combination With Everolimus For Advanced Renal Cell Carcinoma (RCC) 6/3/2016 6:10:35 AM
FDA Approves New Indication For Novartis Pharmaceuticals Corporation (NVS) Drug Afinitor For Progressive, Nonfunctional GI And Lung Neuroendocrine Tumors (NET) 2/29/2016 6:27:24 AM
Novartis Pharmaceuticals Corporation (NVS) Heart Failure Medicine Entresto Substantially Cuts 30-Day Hospital Readmissions, New Post-Hoc Analysis Shows 11/11/2015 6:53:39 AM
Novartis Pharmaceuticals Corporation (NVS) Release: Up to 80% Of ankylosing spondylitis Patients Treated With Cosentyx Show No Spinal X-Ray Progression As Shown In Novartis New Two-Year Observational Data 11/9/2015 11:14:41 AM
Approximately 80% Of Psoriatic Arthritis Patients Treated With Cosentyx Saw No Progression Of Joint Damage As Shown In Novartis Pharmaceuticals Corporation (NVS) New Two-Year Observational Data 11/9/2015 6:42:01 AM
Novartis Pharmaceuticals Corporation (NVS) Is First Company To Receive Number One Ranking Two Years In A Row On Diversityinc Top 50 Companies For Diversity List 4/27/2015 11:14:44 AM
Nine New Analyses Show Novartis Pharmaceuticals Corporation (NVS)' LCZ696 Could Change Course Of Heart Failure For Patients 11/17/2014 3:02:22 PM
12345678910...
//-->